1y return+116.5%S&P 500 +20.9%
3y return+134.5%S&P 500 +68.5%
These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.
$100 invested in its stock picks
Since December 31, 2021: $222 against $157 in the S&P 500.2
Deep Track Capital, LPS&P 500 (SPY)
Top holdings
At the end of June 30, 2026. Change is in shares since the quarter before.2
| Stock | Value | Share of portfolio | Change |
|---|---|---|---|
| GHGuardant Health Inc | $509.1M | 7.5% | +1.6% |
| IMVTImmunovant Inc | $359.9M | 5.3% | −19.0% |
| GPCRStructure Therapeutics Inc | $254.4M | 3.7% | +10.8% |
| PCVXVaxcyte Inc | $250.0M | 3.7% | |
| ALNYAlnylam Pharmaceuticals Inc | $248.3M | 3.7% | New |
| MANEVeradermics Inc | $245.9M | 3.6% | +300.0% |
| TARSTarsus Pharmaceuticals Inc | $230.8M | 3.4% | +1.9% |
| Nuvalent IncCUSIP 670703107 | $220.2M | 3.2% | +29.6% |
| Alkermes PLCCUSIP G01767105 | $209.6M | 3.1% | +11.4% |
| OCULOcular Therapeutix Inc | $193.3M | 2.8% | |
| BMRNBiomarin Pharmaceutical Inc | $189.3M | 2.8% | +187.6% |
| NRIXNurix Therapeutics Inc | $187.7M | 2.8% | +21.9% |
| ORKAOruka Therapeutics Inc | $183.3M | 2.7% | −5.3% |
| ALMSAlumis Inc | $178.6M | 2.6% | −6.3% |
| IONSIonis Pharmaceuticals Inc | $174.4M | 2.6% | +12.8% |
| CMPSCompass Pathways PLC | $172.1M | 2.5% | |
| VERAVera Therapeutics Inc | $171.6M | 2.5% | −2.6% |
| AXSMAxsome Therapeutics Inc. | $171.3M | 2.5% | −36.4% |
| GMABGenmab A/s | $155.2M | 2.3% | +54.2% |
| MLTXMoonlake Immunotherapeutics | $136.3M | 2.0% | +9.2% |
| COAGHemab Therapeutics Hldgs Inc | $132.3M | 1.9% | New |
| TNGXTango Therapeutics Inc | $131.3M | 1.9% | +52.7% |
| DFTXDefinium Therapeutics Inc | $129.4M | 1.9% | −8.3% |
| GRALGrail Inc | $125.3M | 1.8% | +6.5% |
| BCAXBicara Therapeutics Inc | $121.7M | 1.8% |
Best picks still held
How each current holding has done since the quarter it first appeared in its filings (up to six years back).
| Stock | Held since | Return since | Now worth |
|---|---|---|---|
| CMPSCompass Pathways PLC | March 31, 2025 | +394.8% | $172.1M |
| GHGuardant Health Inc | June 30, 2023 | +319.1% | $509.1M |
| ORKAOruka Therapeutics Inc | September 30, 2024 | +288.3% | $183.3M |
| TNGXTango Therapeutics Inc | September 30, 2025 | +272.1% | $131.3M |
| MAZEMaze Therapeutics Inc | March 31, 2025 | +171.0% | $111.4M |
| DFTXDefinium Therapeutics Inc | March 31, 2026 | +148.9% | $129.4M |
| AXSMAxsome Therapeutics Inc. | June 30, 2025 | +134.5% | $171.3M |
| GPCRStructure Therapeutics Inc | March 31, 2023 | +125.6% | $254.4M |
| OCULOcular Therapeutix Inc | December 31, 2023 | +120.2% | $193.3M |
| MBXMbx Biosciences Inc | September 30, 2024 | +112.5% | $95.6M |
Sold off last quarter
- Apellis Pharmaceuticals IncCUSIP 03753U106 was $182.3M
- Centessa Pharmaceuticals PLCCUSIP 152309100 was $125.4M
- BBIOBridgebio Pharma Inc was $62.5M
- Terns Pharmaceuticals IncCUSIP 880881107 was $56.6M
- GERNGeron Corp was $47.3M
- ANIPAni Pharmaceuticals Inc was $46.1M
- Soleno Therapeutics IncCUSIP 834203309 was $36.1M
- Engene Holdings IncCUSIP 29286M105 was $29.8M
- Apogee Therapeutics IncCUSIP 03770N101 was $24.0M
- JANXJanux Therapeutics Inc was $16.5M
Quarter by quarter
| Quarter | Its picks | S&P 500 |
|---|---|---|
| June 30, 2026 | +28.6% | +14.8% |
| March 31, 2026 | −3.0% | −4.6% |
| December 31, 2025 | +32.6% | +2.4% |
| September 30, 2025 | +30.8% | +7.8% |
| June 30, 2025 | +5.3% | +10.5% |
| March 31, 2025 | −6.9% | −4.6% |
| December 31, 2024 | −7.9% | +2.1% |
| September 30, 2024 | +6.8% | +5.4% |
| June 30, 2024 | −3.1% | +4.0% |
| March 31, 2024 | +6.2% | +10.0% |
| December 31, 2023 | +13.8% | +11.2% |
| September 30, 2023 | −4.0% | −3.6% |
| June 30, 2023 | +13.3% | +8.3% |
| March 31, 2023 | −9.2% | +7.0% |
| December 31, 2022 | +11.0% | +7.1% |
| September 30, 2022 | +22.0% | −5.3% |
| June 30, 2022 | −22.1% | −16.5% |
| March 31, 2022 | −12.8% | −4.9% |
Sources
Every number on this page points here. Each one links to the public record.
- 1SEC EDGAR: Deep Track Capital, LP Form 13F filingshttps://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1856083&type=13F-HR&dateb=&owner=include&count=40CIK 1856083
- 2SEC: 13F for the quarter ended June 30, 2026https://www.sec.gov/Archives/edgar/data/1856083/000185608326000004/Filed August 14, 2026 · accession 0001856083-26-000004